Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Monteil, V; Eaton, B; Postnikova, E; Murphy, M; Braunsfeld, B; Crozier, I; Kricek, F; Niederhofer, J; Schwarzbock, A; Breid, H; Devignot, S; Klingstrom, J; Thalin, C; Kellner, MJ; Christ, W; Havervall, S; Mereiter, S; Knapp, S; Jimenez, AS; Bugajska-Schretter, A; Dohnal, A; Ruf, C; Gugenberger, R; Hagelkruys, A; Montserrat, N; Kozieradzki, I; Ali, OH; Stadlmann, J; Holbrook, MR; Schmaljohn, C; Oos

Journal title: Embo Molecular Medicine

Journal number: Embo Molecular Medicine. 14 (8): e15230

Journal publisher: John Wiley & Sons Ltd.

Published year: 2022

DOI identifier: 10.15252/emmm.202115230

ISSN: 1757-4676